Clinical Trial Update: A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low-dose versus standard ticagrelor on platelet function in senior patients after PCI for acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Shanghai Tong Ren Hospital | Conditions: Senior Acute Coronary Syndrome Patients After PCI | Phase 4 | Status: UNKNOWN